Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 32013927)

  • 1. IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer?
    Chen F; Qu M; Zhang F; Tan Z; Xia Q; Hambly BD; Bao S; Tao K
    BMC Cancer; 2020 Feb; 20(1):92. PubMed ID: 32013927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of Interleukin-36s in cancers: A systematic review and meta-analysis.
    Zhang R; Jiang M; Huang M; Yang J; Liu Q; Zhao Z; Bai Y; He T; Zhang D; Zhang M
    Cytokine; 2023 Dec; 172():156397. PubMed ID: 37922622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of IL-36 cytokines in folliculitis and eosinophilic pustular folliculitis.
    Sato S; Chiba T; Nakahara T; Furue M
    Australas J Dermatol; 2020 Feb; 61(1):e39-e45. PubMed ID: 31424098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-34, IL-36 and IL-38 in colorectal cancer-key immunoregulators of carcinogenesis.
    Bao S; Hu R; Hambly BD
    Biophys Rev; 2020 Aug; 12(4):925-930. PubMed ID: 32638330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-38 in colorectal cancer: a potential role in precision medicine.
    Chen F; Zhang F; Tan Z; Hambly BD; Bao S; Tao K
    Cancer Immunol Immunother; 2020 Jan; 69(1):69-79. PubMed ID: 31786620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of interleukin-36α predicts poor prognosis in colorectal cancer patients.
    Wang ZS; Cong ZJ; Luo Y; Mu YF; Qin SL; Zhong M; Chen JJ
    Int J Clin Exp Pathol; 2014; 7(11):8077-81. PubMed ID: 25550854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity.
    Towne JE; Renshaw BR; Douangpanya J; Lipsky BP; Shen M; Gabel CA; Sims JE
    J Biol Chem; 2011 Dec; 286(49):42594-42602. PubMed ID: 21965679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IL-36α, IL-36β, and IL-36γ levels in patients with hidradenitis suppurativa: association with disease characteristics, smoking, obesity, and metabolic syndrome.
    Hayran Y; Allı N; Yücel Ç; Akdoğan N; Turhan T
    Arch Dermatol Res; 2020 Apr; 312(3):187-196. PubMed ID: 31722038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated sputum IL-36 levels are associated with neutrophil-related inflammation in COPD patients.
    Li W; Meng X; Hao Y; Chen M; Jia Y; Gao P
    Clin Respir J; 2021 Jun; 15(6):648-656. PubMed ID: 33559376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
    Wang Y; Yuan W; Ma X; Ma J
    Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease.
    Nishida A; Hidaka K; Kanda T; Imaeda H; Shioya M; Inatomi O; Bamba S; Kitoh K; Sugimoto M; Andoh A
    Inflamm Bowel Dis; 2016 Feb; 22(2):303-14. PubMed ID: 26752465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum IL-36α and IL-36γ levels in patients with systemic lupus erythematosus: Association with disease activity and arthritis.
    Mai SZ; Li CJ; Xie XY; Xiong H; Xu M; Zeng FQ; Guo Q; Han YF
    Int Immunopharmacol; 2018 May; 58():103-108. PubMed ID: 29571080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8
    Wei X; Yao Y; Wang X; Sun J; Zhao W; Qiu L; Zhai W; Qi Y; Gao Y; Wu Y
    Int Immunopharmacol; 2021 Nov; 100():108152. PubMed ID: 34555640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered serum levels of IL-36 cytokines (IL-36α, IL-36β, IL-36γ, and IL-36Ra) and their potential roles in Guillain-Barré syndrome.
    Zhao Z; Zhang R; Gao X; Li H; Liu H
    Medicine (Baltimore); 2020 Dec; 99(52):e23832. PubMed ID: 33350771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-36β provides protection against HSV-1 infection, but does not modulate initiation of adaptive immune responses.
    Milora KA; Uppalapati SR; Sanmiguel JC; Zou W; Jensen LE
    Sci Rep; 2017 Jul; 7(1):5799. PubMed ID: 28724920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-36γ and IL-36 receptor signaling mediate impaired host immunity and lung injury in cytotoxic Pseudomonas aeruginosa pulmonary infection: Role of prostaglandin E2.
    Aoyagi T; Newstead MW; Zeng X; Nanjo Y; Peters-Golden M; Kaku M; Standiford TJ
    PLoS Pathog; 2017 Nov; 13(11):e1006737. PubMed ID: 29166668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-36 signaling pathway dysregulation in Crimean-Congo hemorrhagic fever virus patients: A potential therapeutic avenue.
    Doğan K; Büyüktuna SA
    J Med Virol; 2024 Jan; 96(1):e29347. PubMed ID: 38152020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of interleukin 36 in chronic rhinosinusitis and its contribution to chemokine secretion and increased epithelial permeability.
    Joo YH; Kim HK; Hak Choi I; Han HM; Lee KJ; Kim TH; Lee SH
    Cytokine; 2020 Jan; 125():154798. PubMed ID: 31430658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.
    Zeng J; Tang ZH; Liu S; Guo SS
    World J Gastroenterol; 2017 Mar; 23(10):1780-1786. PubMed ID: 28348483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum IL-36β and IL-36γ levels in patients with neuromyelitis optica spectrum disorders: association with disease activity.
    Yang CS; Zhang QX; Deng Y; Zhou BJ; Zhang LJ; Li LM; Qi Y; Wang J; Yang L; Shi FD
    BMC Neurol; 2019 Aug; 19(1):185. PubMed ID: 31382910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.